Shares Of Bluebird Bio Surge 60% At Market Open On Positive Results Against Rare Blood Disease
December 09, 2014 at 13:41 PM EST
Bluebird bio achieves early success in providing gene therapy to chronic blood transfusion patients.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.